Search


Current filters:
New search
Add filters

Refine your search


Results 1-10 of 117.
Item hits:
Thumbnail
WHO Expert Committee on Biological Standardization [meeting held in Geneva from 21 to 27 September 1982] : thirty-third report
WHO Expert Committee on Biological Standardization; World Health Organization ( 1983 )
Thumbnail
Comité de Expertos de la OMS en Patrones Biol'ogicos [se reuni'o en Ginebra del 30 de septiembre al 5 de octubre de 1963] : 16 i̜nforme
WHO Expert Committee on Biological Standardization; World Health Organization ( 1964 )
Thumbnail
Comité d' experts de la standardisation biologique [réuni à Genève du 16 au 21 septembre 1957] : onzième rapport
WHO Expert Committee on Biological Standardization; World Health Organization ( 1958 )
Thumbnail
Comité de Expertos en Estandarizaci'on Biol'ogica [se reuni'o en Ginebra del 8 al 13 de octubre de 1956] : décimo informe
WHO Expert Committee on Biological Standardization; World Health Organization ( 1957 )
Thumbnail
WHO Expert Committee on Biological Standardization [meeting held in Geneva from 27 September to 2 October 1965] : eighteenth report
WHO Expert Committee on Biological Standardization; World Health Organization ( 1966 )
Thumbnail
Comité de expertos en patrones biol'ogicos [se reuni'o en Ginebra del 16 al 21 de septiembre de 1957] : undécimo informe
WHO Expert Committee on Biological Standardization; World Health Organization ( 1958 )
Thumbnail
WHO Expert Committee on Biological Standardization [meeting held in Geneva from 12 to 18 November 1985] : thirty-sixth report
WHO Expert Committee on Biological Standardization; World Health Organization ( 1987 )
Abstract

Announces changes in the status or development of 34 biologicals. The report also presents full details on revised requirements for the manufacturing and national control of tuberculins, dried BCG vaccine, and continuous cell lines, followed by amended requirements for inactivated poliomyelitis vaccine and an addendum to the requirements for antimicrobic susceptibility. A concluding section presents data documenting the history of the production of the WHO primary seed of 17D yellow fever virus to be used in the production of vaccine. As with previous reports from this committee, the present work will serve as both an indispensable reference for manufacturers and control authorities and an integral part of WHOs efforts to assure the production of safe, reliable, and potent biologicals

Thumbnail
Comité de Expertos de la OMS en Patrones Biol'ogicos [se reuni'o en Ginebra del 28 de septiembre al 3 de octubre de 1964] : 17 i̜nforme
WHO Expert Committee on Biological Standardization; World Health Organization ( 1964 )
Thumbnail
WHO Expert Committee on Biological Standardization [meeting held in Geneva from 12 to 19 October 1993] : forty-fourth report
WHO Expert Committee on Biological Standardization; World Health Organization ( 1994 )
Abstract

Reports the work of an expert committee commissioned to identify and establish international standards and reference reagents for biological substances. Held and distributed by WHO International Laboratories for Biological Standards, these reference materials are widely used by national control authorities and manufacturers to ensure worldwide uniformity when designating the potency, activity, or specificity of biologicals used in prophylaxis, therapy or diagnosis of disease. The committee also issues guidelines and detailed requirements for the manufacturing and quality control of selected biologicals. The report has two parts. The first part briefly considers general issues affecting the committee s work, explains the decision to issue new or revised requirements for two vaccines, and reviews the need to establish, replace, or discontinue some 55 international reference materials. Ten new or replacement reference materials were established. The second and most extensive part issues detailed requirements for the manufacturing and quality control of two vaccines. Revised requirements were issued for live varicella vaccine. Revisions reflect the extensive experience gained by manufacturers since the initial requirements were established in 1984. The committee also issued new requirements for inactivated vaccine against haemorrhagic feverwith renal syndrome, an acute interstitial nephropathy caused by viruses belonging to the Hantavirus genus of the family Bunyaviridae

Comité de Expertos en Patrones Biol'ogicos [se reuni'o en Ginebra del 31 de agosto al 5 de septiembre de 1959] : 13 i̜nforme
WHO Expert Committee on Biological Standardization; World Health Organization ( 1960 )